
Home » SOLVAY PHARMACEUTICALS AWARDED $298 MILLION, FIVE-YEAR CONTRACT
SOLVAY PHARMACEUTICALS AWARDED $298 MILLION, FIVE-YEAR CONTRACT
Solvay Pharmaceuticals announced that it was awarded a $298 million, five-year contract from the United States Department of Health and Human Services (HHS) to develop cell-based influenza vaccines and plan for domestic manufacturing capacity in the U.S.
Webbolt
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
08Sep
-
15Sep
-
20Sep
-
21Sep
-
22Sep
-
11Oct